Recent Finacing
Recent Raise
Olaris operates a metabolomics diagnostics platform using NMR-based metabolite detection and machine learning to produce noninvasive urine assays, including myOLARIS‑KTdx for kidney transplant graft surveillance.
Focus Areas
Recent Investors
Funding rounds
Investors
